Matthew L. Posard Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Matthew L. Posard.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Matthew L. Posard. Matthew L. Posard is a Sr VP & General Manager in ILLUMINA INC ($ILMN) and a Sr VP & GM, Consumer Genomics in ILLUMINA INC ($ILMN) and a Director in HALOZYME THERAPEUTICS INC ($GYHT) and a Chief Commercial Officer in Trovagene, Inc. ($XNOM.OB) and a Director in Talis Biomedical Corp ($TLIS) and a Director in DermTech, Inc. ($DMTK).

Address: 5200 ILLUMINA WAY SAN DIEGO 92122 CA

Companies in which Matthew L. Posard is an Insider

Cardiff Oncology, Inc.

Trading Symbol: XNOM.OB
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Matthew L. Posard: Chief Commercial Officer
Holdings: 0 shares
Latest Transaction: Jan 06 2016

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

DermTech, Inc.

Trading Symbol: DMTK
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of Matthew L. Posard: Director
Holdings: 86,863 shares
Latest Transaction: Jan 13 2021

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 51,600
Shares Sold: 0
Share Difference: +51,600
Value Difference: -$1,067,323

HALOZYME THERAPEUTICS, INC.

Trading Symbol: GYHT
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Matthew L. Posard: Director
Holdings: 128,983 shares
Latest Transaction: May 06 2021

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 6x
Sell: 0x
Shares Bought: 70,932
Shares Sold: 0
Share Difference: +70,932
Value Difference: $0

ILLUMINA, INC.

Trading Symbol: ILMN
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of Matthew L. Posard: Sr VP & General Manager, Sr VP & GM, Consumer Genomics
Holdings: 30,858 shares
Current Value: $5,025,225
Latest Transaction: May 30 2013
$ILMN Market Capitalization: $23.92B
$ILMN Previous Close: $162.85

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Talis Biomedical Corp

Trading Symbol: TLIS
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of Matthew L. Posard: Director
Holdings: 62,500 shares
Latest Transaction: Feb 19 2021

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 0x
Shares Bought: 62,500
Shares Sold: 0
Share Difference: +62,500
Value Difference: -$1,000,000

Latest Insider Trading Transactions of Matthew L. Posard

Sentiment: All, XNOM.OB, DMTK, GYHT, ILMN, TLIS

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 06 2021GYHTHALOZYME THERAPEUT ...Posard Matthew L.DirectorGrantA0.005,2300128,983123.8 K to 129 K (+4.23 %)
Feb 19 2021TLISTalis Biomedical C ...Posard Matthew L.DirectorBuyP16.0062,5001,000,00062,5000 to 62.5 K
Jan 13 2021DMTKDermTech, Inc.Posard Matthew L.DirectorBuyP29.5033,898999,99186,86353 K to 86.9 K (+64.00 %)
Jun 19 2020DMTKDermTech, Inc.Posard Matthew L.DirectorGrantA0.008,000052,96545 K to 53 K (+17.79 %)
May 01 2020GYHTHALOZYME THERAPEUT ...Posard Matthew L.DirectorGrantA0.008,8290123,753114.9 K to 123.8 K (+7.68 %)
May 01 2020DMTKDermTech, Inc.Posard Matthew L.DirectorOption ExerciseM6.949,70267,3320
May 01 2020DMTKDermTech, Inc.Posard Matthew L.DirectorBuyM6.949,70267,33244,96535.3 K to 45 K (+27.51 %)

View all Matthew L. Posard insider transactions.